Clinical Trial: Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access

Official Title: Compassionate Use Treatment Protocol I4V-MC-JAGA: Treatment of Conditions Expected to Benefit From JAK 1/2 Inhibition: CANDLE, CANDLE-Related Conditions, SAVI and Severe Juvenile

Brief Summary: The Requesting Physician/Investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.

Detailed Summary:
Sponsor: Eli Lilly and Company

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Eli Lilly and Company

Dates:
Date Received: November 5, 2012
Date Started:
Date Completion:
Last Updated: February 28, 2017
Last Verified: February 2017